Ding Ruihua, Hung Kuo-Chan, Mitra Anindita, Ung Lloyd W, Lightwood Daniel, Tu Ran, Starkie Dale, Cai Liheng, Mazutis Linas, Chong Shaorong, Weitz David A, Heyman John A
John A. Paulson School of Engineering and Applied Sciences, Harvard University 11 Oxford Street Cambridge MA 02138 USA
Department of Chemistry and Chemical Biology, Harvard University Cambridge MA 02138 USA.
RSC Adv. 2020 Jul 20;10(45):27006-27013. doi: 10.1039/d0ra04328a. eCollection 2020 Jul 15.
Monoclonal antibodies are powerful tools for scientific research and are the basis of numerous therapeutics. However, traditional approaches to generate monoclonal antibodies against a desired target, such as hybridoma-based techniques and display library methods, are laborious and suffer from fusion inefficiency and display bias, respectively. Here we present a platform, featuring droplet microfluidics and a bead-based binding assay, to rapidly identify and verify antigen-binding antibody sequences from primary cells. We used a defined mixture of hybridoma cells to characterize the system, sorting droplets at up to 100 Hz and isolating desired hybridoma cells, comprising 0.1% of the input, with a false positive rate of less than 1%. We then applied the system to once-frozen primary B-cells to isolate rare cells secreting target-binding antibody. We performed RT-PCR on individual sorted cells to recover the correctly paired heavy- and light-chain antibody sequences, and we used rapid cell-free protein synthesis to generate single-chain variable fragment-format (scFv) antibodies from fourteen of the sorted cells. Twelve of these showed antigen-specific binding by ELISA. Our platform facilitates screening animal B-cell repertoires within days at low cost, increasing both rate and range of discovering antigen-specific antibodies from living organisms. Further, these techniques can be adapted to isolate cells based on virtually any secreted product.
单克隆抗体是科学研究的有力工具,也是众多治疗方法的基础。然而,传统的针对所需靶标产生单克隆抗体的方法,如基于杂交瘤的技术和展示文库方法,分别存在操作繁琐、融合效率低和展示偏差等问题。在此,我们展示了一个平台,其特点是液滴微流控技术和基于珠子的结合测定法,用于从原代细胞中快速鉴定和验证抗原结合抗体序列。我们使用了一组确定的杂交瘤细胞混合物来表征该系统,以高达100赫兹的频率对液滴进行分选,并分离出所需的杂交瘤细胞,其占输入细胞的0.1%,假阳性率低于1%。然后,我们将该系统应用于一次冻存的原代B细胞,以分离分泌靶标结合抗体的稀有细胞。我们对单个分选细胞进行逆转录聚合酶链反应(RT-PCR),以恢复正确配对的重链和轻链抗体序列,并使用无细胞快速蛋白质合成技术从14个分选细胞中生成单链可变片段形式(scFv)的抗体。其中12个通过酶联免疫吸附测定(ELISA)显示出抗原特异性结合。我们的平台有助于在数天内以低成本筛选动物B细胞库,提高从活生物体中发现抗原特异性抗体的速度和范围。此外,这些技术可适用于基于几乎任何分泌产物来分离细胞。